STUDY: How Brazilian City Cut Hospitalizations And Mortality In Half By Offering Ivermectin To Everyone

According to a study, a Brazilian city cut hospitalizations and mortality in half by offering Ivermectin to everyone pre-vaccine.

During the start of the pandemic, Ivermectin was introduced as a prophylaxis against the disease in the southern Brazilian city of Itajai.

In the span of July and December 2020, approximately 220,000 people received 0.2 mg/kg/day (approximately 18 mg per person weighing 200 pounds) as a two-day treatment option once per every two weeks.

133,051 people received them and 87,466 did not receive them.

After reviewing the data, a team of researchers from various Brazilian institutes, the University of Toronto and EAFIT in Colombia concluded in an initial pre-print version of the study (read below) released in December that hospitalization and mortality rates had been reduced in the Ivermectin group over the period of seven months.

The authors adjusted for the relevant intervention ...

Limited Time

Full Access

$10
Monthly

Included:

  • Access to All Articles.
  • One Plan. No Tiers.
  • No Ads.
  • Cancel anytime.
register now

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].